share_log

加拿大投资银行集团:维持Biomarin Pharmaceutical(BMRN.US)评级,由持有调整至持有评级, 目标价由91.00美元调整至89.00美元。

Zhitong Finance ·  Apr 26 08:56

加拿大投资银行集团:维持Biomarin Pharmaceutical(BMRN.US)评级,由持有调整至持有评级, 目标价由91.00美元调整至89.00美元。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment